Royce & Associates LP Ani Pharmaceuticals Inc Transaction History

Royce & Associates LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$26.38 - $33.1 $27,329 - $34,291	-1,036 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$29.93 - $50.1 $9,966 - $16,683	333 Added 47.37%	1,036 $34,000
Q1 2020 May 12, 2020	BUY	$30.35 - $67.14 $4,370 - $9,668	144 Added 25.76%	703 $29,000
Q4 2019 Feb 06, 2020	BUY	$55.65 - $79.83 $2,448 - $3,512	44 Added 8.54%	559 $34,000
Q3 2019 Nov 13, 2019	BUY	$64.7 - $85.39 $11,840 - $15,626	183 Added 55.12%	515 $38,000
Q2 2019 Aug 12, 2019	SELL	$67.77 - $82.2 $4,201 - $5,096	-62 Reduced 15.74%	332 $27,000
Q1 2019 May 09, 2019	BUY	$45.83 - $70.54 $2,199 - $3,385	48 Added 13.87%	394 $28,000
Q4 2018 Feb 11, 2019	SELL	$41.17 - $56.44 $2,387 - $3,273	-58 Reduced 14.36%	346 $16,000
Q3 2018 Nov 13, 2018	BUY	$52.95 - $71.34 $21,391 - $28,821	404 New	404 $23,000

211

18.5M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $1.02B
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

Stay updated on Royce & Associates LP with notifications on news.